Natural killer cells for cancer immunotherapy: a new CAR is catching up.
出版信息
EBioMedicine. 2019 Jan;39:1-2. doi: 10.1016/j.ebiom.2019.01.018.
Abstract
摘要
相似文献
1
Natural killer cells for cancer immunotherapy: a new CAR is catching up.用于癌症免疫治疗的自然杀伤细胞：一种新型嵌合抗原受体正在迎头赶上。
EBioMedicine. 2019 Jan;39:1-2. doi: 10.1016/j.ebiom.2019.01.018.
2
Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy.自然杀伤细胞和嵌合抗原受体修饰 NK-92 细胞在肿瘤免疫治疗中的当前应用。
Int J Mol Sci. 2019 Jan 14;20(2):317. doi: 10.3390/ijms20020317.
3
Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy.工程嵌合抗原受体-自然杀伤细胞用于癌症免疫治疗。
Immunotherapy. 2020 Jun;12(9):653-664. doi: 10.2217/imt-2019-0139. Epub 2020 May 21.
4
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer.嵌合抗原受体表达的自然杀伤细胞用于癌症的免疫治疗。
Front Immunol. 2018 Feb 15;9:283. doi: 10.3389/fimmu.2018.00283. eCollection 2018.
5
Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.优化 CAR NK 细胞的细胞内信号结构域用于 HIV 免疫治疗：全面综述。
Drug Discov Today. 2019 Apr;24(4):983-991. doi: 10.1016/j.drudis.2019.02.002. Epub 2019 Feb 13.
6
Chimeric Antigen Receptor (CAR) T-Cell Therapy.嵌合抗原受体（CAR）T细胞疗法
JAMA Oncol. 2017 Nov 1;3(11):1595. doi: 10.1001/jamaoncol.2017.2989.
7
The trials and tribulations of CAR-T cell development for cancer and AIDS.嵌合抗原受体T细胞（CAR-T）用于癌症和艾滋病治疗的研发历程与艰辛。
Nat Med. 2019 Aug;25(8):1183. doi: 10.1038/s41591-019-0538-8.
8
Reformation in chimeric antigen receptor based cancer immunotherapy: Redirecting natural killer cell.嵌合抗原受体肿瘤免疫治疗的改革：重定向自然杀伤细胞。
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):200-215. doi: 10.1016/j.bbcan.2018.01.005. Epub 2018 Jan 31.
9
CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment.CRISPR/Cas9与嵌合抗原受体T细胞（CAR-T细胞），癌症免疫治疗中两项革命性技术的协作，癌症成功治疗指南。
Hum Immunol. 2018 Dec;79(12):876-882. doi: 10.1016/j.humimm.2018.09.007. Epub 2018 Sep 24.
10
Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.嵌合抗原受体修饰 T 细胞疗法的临床前模型。
Hum Gene Ther. 2018 May;29(5):534-546. doi: 10.1089/hum.2017.243. Epub 2018 Mar 14.
引用本文的文献
1
Recurrent Glioblastoma-Molecular Underpinnings and Evolving Treatment Paradigms.复发性胶质母细胞瘤的分子基础和不断发展的治疗范例。
Int J Mol Sci. 2024 Jun 19;25(12):6733. doi: 10.3390/ijms25126733.
2
CNS Toxicity of Immunotherapy.免疫疗法的中枢神经系统毒性
Clin Res (Milpitas). 2020 Sep;6(2). doi: 10.16966/2469-6714.157. Epub 2020 Jun 24.
3
The state of cell and gene therapy in 2023.2023 年的细胞和基因治疗现状。
Mol Ther. 2023 Dec 6;31(12):3376-3388. doi: 10.1016/j.ymthe.2023.11.001. Epub 2023 Nov 4.
4
Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma.自然杀伤细胞的觉醒：释放针对神经胶质瘤的癌症免疫循环。
Cell Death Dis. 2022 Jul 8;13(7):588. doi: 10.1038/s41419-022-05041-y.
5
Investigating the susceptibility of treatment-resistant oesophageal tumours to natural killer cell-mediated responses.研究自然杀伤细胞介导的反应对治疗抵抗性食管肿瘤的敏感性。
Clin Exp Med. 2023 Jun;23(2):411-425. doi: 10.1007/s10238-022-00811-6. Epub 2022 Apr 1.
6
Cell-mediated immune resistance in cancer.癌症中的细胞介导免疫抵抗
Cancer Drug Resist. 2020;3(2):232-251. doi: 10.20517/cdr.2019.98. Epub 2020 Jan 2.
7
The Right Partner in Crime: Unlocking the Potential of the Anti-EGFR Antibody Cetuximab Combination With Natural Killer Cell Chartering Immunotherapeutic Strategies.最佳犯罪搭档：解锁抗 EGFR 抗体西妥昔单抗联合自然杀伤细胞特许免疫治疗策略的潜力。
Front Immunol. 2021 Sep 7;12:737311. doi: 10.3389/fimmu.2021.737311. eCollection 2021.
8
Global Perspective on the Development of Genetically Modified Immune Cells for Cancer Therapy.癌症治疗中基因改造免疫细胞发展的全球视角。
Front Immunol. 2021 Feb 15;11:608485. doi: 10.3389/fimmu.2020.608485. eCollection 2020.
9
Neglected No More: Emerging Cellular Therapies in Traumatic Injury.不再被忽视：创伤中新兴的细胞疗法。
Stem Cell Rev Rep. 2021 Aug;17(4):1194-1214. doi: 10.1007/s12015-020-10086-7. Epub 2021 Jan 8.
10
Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield.用于实体瘤的创新型嵌合抗原受体T细胞疗法；当前嵌合抗原受体T细胞之矛与肿瘤防御盾的较量
Cancers (Basel). 2020 Jul 28;12(8):2087. doi: 10.3390/cancers12082087.
Zotero 插件